A 38-year-old woman with a history of repeated pregnancies and lactation presents with breast tissue enlargement. Histology shows increased number of lobules and acini. Which is the most common stimulus for mammary gland hyperplasia in women of reproductive age?

Explanation

## Most Common Stimulus for Mammary Gland Hyperplasia **Key Point:** Estrogen and progesterone are the most common and physiologic stimuli for mammary gland hyperplasia in women of reproductive age, particularly during pregnancy and the luteal phase of the menstrual cycle. ### Hormonal Control of Breast Tissue Growth #### Estrogen - **Effect:** Stimulates ductal growth and proliferation - **Receptor:** Estrogen receptor (ER) on ductal epithelium - **Timing:** Rises in follicular phase; further elevated in pregnancy #### Progesterone - **Effect:** Stimulates lobular and acinar development - **Receptor:** Progesterone receptor (PR) on lobular epithelium - **Timing:** Peaks in luteal phase; markedly elevated in pregnancy #### Combined Action in Pregnancy 1. **First trimester:** Estrogen-driven ductal proliferation 2. **Second/third trimester:** Progesterone-driven acinar differentiation and lactogenic gene expression 3. **Postpartum:** Prolactin maintains lactation; estrogen/progesterone withdrawal triggers involution ### Comparison of Hormonal Drivers | Hormone | Effect on Breast | Timing | Physiologic Role | |---------|------------------|--------|------------------| | **Estrogen + Progesterone** | Ductal + lobular hyperplasia | Menstrual cycle, pregnancy | Primary growth stimulus | | Prolactin | Lactogenic differentiation | Pregnancy, postpartum | Milk synthesis, not growth | | Thyroid hormone | Permissive (indirect) | Continuous | Supports metabolism | | Growth hormone | Permissive (indirect) | Continuous | Supports general growth | **High-Yield:** Breast hyperplasia is **estrogen and progesterone-dependent**. This is why: - Breast tissue enlarges in pregnancy (both hormones ↑) - Breast swelling occurs in luteal phase (progesterone ↑) - Estrogen-blocking agents (tamoxifen) cause breast atrophy - Estrogen + progesterone replacement therapy increases breast density **Mnemonic:** **EPL** = **E**strogen, **P**rogesterone → Lobular hyperplasia (remember: P for Progesterone → acini/lobules) ### Why Other Hormones Are Not Primary Drivers **Prolactin alone:** Prolactin is essential for *lactation* (milk synthesis) but NOT for breast tissue growth. Hyperprolactinemia causes galactorrhea, not significant breast hyperplasia. Prolactin acts *after* estrogen/progesterone have prepared the tissue. **Thyroid hormone & Growth hormone:** These are permissive (support general metabolism and growth) but are not specific drivers of breast hyperplasia. Hypothyroidism does not prevent breast growth; growth hormone deficiency does not selectively reduce breast tissue. **Clinical Pearl:** Estrogen receptor positivity (ER+) in breast cancer reflects the normal estrogen-dependence of mammary epithelium. This is why ER+ tumors respond to endocrine therapy (tamoxifen, aromatase inhibitors). [cite:Robbins 10e Ch 3]